Therapeutic development subsidiary of the Aptorum Group in Hong Kong, which holds and advances the group's medicine programmes. Works on small molecule candidates for infectious disease, oncology and metabolic conditions, manages preclinical and early clinical studies with contract partners, and licenses compounds from universities and research institutes for further development.
Aucun commentaire disponible.
Laissez votre note & commentaire